SAM #36C26126Q0993

Sole Source Specialized Laboratory Medical Testing Services for VA Palo Alto to Mayo Collaborative Services, Inc.

This notice announces the Department of Veterans Affairs' intent to award a sole source contract to Mayo Collaborative Services, Inc. for specialized laboratory medical testing services. - Agency: Department of Veterans Affairs, Network Contracting Office 21 (NCO 21), VA Palo Alto Health Care System - Contract Type: Sole source, firm-fixed price - Vendor: Mayo Collaborative Services, Inc. - Services Required: - Specialized laboratory tests not available within VA or VISN 21 labs - Tests include CNS Demyelinating Disease Evaluation, CRMP-5 Neuronal IgG Titer, CRMP-5-IgG Western Blot, GAD65 Antibody Assay, Glycine Receptor Alpha1 IgG Cell Binding Assay, LDH (Body Fluid), MOG-IgG-1 FACS Titer Assay, NMO/Aquaporin-4 FACS IgG Assay Titer, and Paraneoplastic Vision Loss Evaluation - Contractor must provide all personnel, equipment, supplies, specimen containers, and forms - Testing must be performed Monday through Friday during business hours, with timely processing due to specimen fragility - Results must be reported via Laboratory Information System or fax; proficiency and repeat testing required if results are inconsistent - Compliance Requirements: - Contractor must hold CLIA certification, comply with HIPAA, and adhere to VA security policies - Testing staff must have required licenses and certifications - Period of Performance: - Base year (starting October 1, 2026) plus three or four one-year option periods (total up to five years) - NAICS Code: 621511 - Interested parties must demonstrate both capability and authorization from Mayo Collaborative Services, Inc. to be considered

Description

The Department of Veterans Affairs, NCO 21, intends to award a sole source firm fixed price contract to Mayo Collaborative Services, Inc., for a base year plus four option years, because we believe they are the sole source provider for specialized laboratory medical testing services. We believe there are no authorized third parties that can provide these specialized laboratory medical testing services that can satisfy this requirement. A draft Statement of Work (SOW) is attached. If you believe that your company is capable and authorized to perform these services in accordance with the SOW, please provide your information and capability along with an authorization letter from Mayo Collaborative Services, Inc., by responding to angela.gerlitzki1@va.gov no later than July 24, 2026, by 10 am PST. The applicable NAICS Code is 621511 and the size standard is $41.5 Million. This notice of intent is not a request for competitive quotes. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses received to this notice is solely within the discretion of the Government. Testing: CNS Demyelinating Disease Evaluation, Serum Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum Collapsin Response-Mediator Protein-5-IgG, Western Blot, Serum Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid Glycine Receptor Alpha1 IgG, Cell Binding Assay, Serum Lactate Dehydrogenase (LDH), Body Fluid Myelin Oligodendrocyte Glycoprotein (MOG-IgG-1) Fluorescence-Activated Cell Sorting (FACS) Titer Ass Neuromyelitis Optica (NMO)/Aquaporin-4 FACS IgG Assay Titer, Serum Paraneoplastic Vision Loss Evaluation, Serum

View original listing